Great week for Puma Biotechnology, Inc. (NASDAQ:PBYI) institutional investors after losing 32% over the previous year - Simply Wall St News
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
PBYI Stock Price and Chart — NASDAQ:PBYI — TradingView
Is Puma Biotechnology (PBYI) Stock a Solid Choice Right Now?
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
PBYI | Puma Biotechnology Stock Price
PBYI Stock Price and Chart — NASDAQ:PBYI — TradingView
Here's Why Puma Biotechnology Tumbled Today | The Motley Fool
These 2 Biotech Stocks Cratered in 2015 -- Is 1 Now a Buy? | The Motley Fool
Puma (PBYI): Recent Rally Looks Overdone, Unsupported With Fundamentals | Seeking Alpha
Puma Biotechnology
Here's Why Puma Biotechnology Inc. Is Getting Beaten Down Today | The Motley Fool
SEC charges former Puma biotech exec with $1.1 million in insider trading
Puma Biotech Plunges on Sharp Drop in Cancer-Drug Sales - TheStreet
Can Puma Biotechnology Inc (PBYI) Stock Rise to the Top of Healthcare Sector Tuesday?
Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity - Market Exclusive
Puma (PBYI): Recent Rally Looks Overdone, Unsupported With Fundamentals | Seeking Alpha
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Breakeven On The Horizon For Puma Biotechnology, Inc. (NASDAQ:PBYI) | Nasdaq
Why Shares in Puma Biotechnology Inc. Are Plunging | The Motley Fool
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
Puma Biotech's (PBYI) Nerlynx Aids Top Line, Overdependence a Woe
Puma's (PBYI) Earnings and Revenues Beat Estimates in Q1
Puma Biotech (PBYI) Up More Than 95% in 3 Months: Here's Why
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
